X @Bloomberg

Novartis(US:NVS) Bloomberg·2025-10-01 07:22

Novartis wins US approval for a new treatment for a hives-like skin condition, bolstering the drugmaker’s push into disorders of the immune system https://t.co/kEkx94YzpL ...